Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
Public ClinicalTrials.gov record NCT00707993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of alogliptin, once daily (QD), compared to glipizide in elderly diabetic patients who have not received treatment or are on a single oral medication.
Study identification
- NCT ID
- NCT00707993
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 441 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 65 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2008 (Type not available)
- Primary completion
- Aug 2010 (Actual)
- Completion
- Aug 2010 (Actual)
- Last update posted
- May 24, 2013
2008 – 2010
United States locations
- U.S. sites
- 36
- U.S. states
- 17
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Alexander City | Alabama | — | — |
| Not listed | Foothill Ranch | California | — | — |
| Not listed | Huntington Park | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Redlands | California | — | — |
| Not listed | Prospect | Connecticut | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Fort Myers | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | Winter Park | Florida | — | — |
| Not listed | Roswell | Georgia | — | — |
| Not listed | Aurora | Illinois | — | — |
| Not listed | La Porte | Indiana | — | — |
| Not listed | South Bend | Indiana | — | — |
| Not listed | Salisbury | Maryland | — | — |
| Not listed | Clarkston | Michigan | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Hamilton | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Beachwood | Ohio | — | — |
| Not listed | Westlake | Ohio | — | — |
| Not listed | Zanesville | Ohio | — | — |
| Not listed | Bensalem | Pennsylvania | — | — |
| Not listed | Aiken | South Carolina | — | — |
| Not listed | Greenville | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Taylors | South Carolina | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Pasadena | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Tomball | Texas | — | — |
| Not listed | Ogden | Utah | — | — |
| Not listed | Salt Lake City | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00707993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2013 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00707993 live on ClinicalTrials.gov.